Cadence Biomedical
Private Company
Total funding raised: $7.5M
Overview
Cadence Biomedical is a private medical device company focused on neurorehabilitation through its flagship product, Kickstart. This wearable device provides powered assistance to stabilize the hip and leg, guiding users through a proper step pattern to re-learn walking. The device is covered by Medicare and private insurance, targeting both individual patients for home use and rehabilitation clinics for therapeutic applications. The company appears to be in a commercial, revenue-generating stage, leveraging clinical evidence and user testimonials to drive adoption.
Technology Platform
Wearable exotendon device providing mechanical, reflexive step assistance to stabilize the hip and leg and promote re-learning of natural gait patterns without electrical stimulation.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Kickstart competes in the assistive and rehabilitative device market, facing competition from robotic exoskeletons (e.g., Ekso Bionics, ReWalk), functional electrical stimulation systems (e.g., Bioness), and traditional gait training equipment. Its differentiation lies in its unique exotendon mechanism, lightweight design, and focus on promoting reflexive, patient-initiated movement rather than fully pre-programmed assistance.